Stockreport

Novartis and UK-based Relation forge R&D deal worth up to $1.7bn [Yahoo! Finance]

Monte Rosa Therapeutics, Inc.  (GLUE) 
PDF Through the agreement, the Swiss big pharma company will hand over $55m in upfront, equity investment and R&D funding payments for the global development and commercial [Read more]